Course overview
Pharma 4.0 discusses the application of digital technology to the unique workflows of pharmaceutical development and manufacturing. One workflow screaming out for a digital intervention is technology transfer, and it’s clear that traditional approaches to technology transfer are no longer sufficient to meet the growing pressures (internally and externally) for speed and operational efficiency. Because of this, pharmaceutical and biotechnology organisations find themselves confronted with an operational bottleneck that has implications for patients as well as the company’s bottom line.
Technology transfer, the process of moving pharmaceutical products and manufacturing processes from development to production or between production facilities, is pivotal for ensuring life-changing therapies reach patients expediently. However, these processes are often hindered by unstructured data, legacy data management systems, and siloed communication. Taking a digital approach to technology transfer offers a transformative solution, enabling life changing therapies to get to market that much faster. Both satisfying the demand of the patient population that requires these medicines, and avoiding the consequences of lost revenue and eroded market share due to product launch or product release delays.
This course explores how cutting-edge digital tools and novel strategies can address these long-standing challenges. By leveraging digital solutions, companies can not only accelerate the transfer of critical knowledge but also foster innovation and gain an edge in increasingly competitive markets. Whether you're looking to modernise existing workflows or build a future-ready tech transfer framework, this course will provide the knowledge and tools to succeed.
Key topics covered in this exciting lunchtime session include:
- What is Pharma 4.0?
- What is a technology transfer?
- What are the stages of technology transfer?
- What are the different types of Technology Transfers?
- The challenges of today’s tech transfers
- Outlining the key characteristics of a single source of truth for Chemistry, Manufacturing and Controls (CMC)
- How to leverage the CMC source of truth to accelerate tech transfers
- Defining the stages of a digital-native tech transfer
- How cloud-based collaboration can shift mindset from “tech transfer” to “tech sharing”
- Real world use cases of digital tech transfer
CPD Hours: 1
Speakers
Lewis Shipp
Lewis Shipp is a published pharmaceutical scientist and a recognised expert in drug development & manufacturing across a range of therapeutic modalities. Lewis currently works at the intersection of science & technology as a Digital CMC Specialist at QbDVision, helping organisations both large & small leverage digital technology to accelerate the delivery of therapies to patients. Additionally, Lewis has contributed to ISPE's Pharma 4.0 Special Interest Group & BioPhorum's Technology Strategy Forum as an SME in the application of digital technology to solve business process challenges within the pharmaceutical industry. Lewis has also given several presentations at internationally recognised conferences on varying topics pertaining to digitally-enabled drug development and manufacturing.
